M. Bewernitz

发表

Biclustering EEG data from epileptic patients treated with vagus nerve stimulation

P. Pardalos, G. Ghacibeh, S. Busygin, 2007 .

Data mining and time series analysis of brain dynamical behavior with applications in epilepsy

M. Bewernitz, Michael Bewernitz, 2008 .

Quantification of the impact of vagus nerve stimulation parameters on electroencephalographic measures

P. Pardalos, B. Uthman, O. Seref, 2007 .

CENTER FOR DRUG EVALUATION AND RESEARCH

M. Bewernitz, A. Men, A. Bhattaram, 2007 .

Thromboelastographic and pharmacokinetic profiles of micro‐ and macro‐emulsions of propofol in swine

D. Shah, D. Dennis, H. Derendorf, 2010, Biopharmaceutics & drug disposition.

Population pharmacokinetics of steady‐state carbamazepine in Egyptian epilepsy patients

H. Derendorf, M. Bewernitz, S. Sabarinath, 2012, Journal of clinical pharmacy and therapeutics.

Model‐Informed Drug Development in Pediatric Dose Selection

Justin C. Earp, Jiang Liu, Xinyuan Zhang, 2021, Journal of clinical pharmacology.

Role of Model‐Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling

Hao Zhu, Chao Liu, Yaning Wang, 2019, Journal of clinical pharmacology.

Electroencephalogram-based pharmacodynamic measures: a review

Hartmut Derendorf, Michael Bewernitz, H. Derendorf, 2012, International journal of clinical pharmacology and therapeutics.

Optimization of epilepsy treatment with vagus nerve stimulation

Basim M. Uthman, Georges A. Ghacibeh, Michael Bewernitz, 2007 .

Electroencephalogram effects of armodafinil: Comparison with behavioral alertness

M. Ding, S. Eisenschenk, J. Cibula, 2013, Journal of clinical pharmacology.

Extrapolation of Efficacy from Adults to Pediatric Patients of Drugs for Treatment of Partial Onset Seizures: A Regulatory Perspective

B. Dunn, R. Uppoor, E. Bastings, 2022, Clinical pharmacology and therapeutics.